Quick Research
Filters Clear All
Any Time
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 26,969 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway (2022-02-27)
Journal: Bioengineered (2022) IF: 4.9Products Cited: Human Oral Epithelial cells, Human Oral Epithelial cells Complete Medium -
Propofol protects ardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2/glutathione peroxidase 4 signaling pathways (2022-04-01)
Journal: Bioengineered (2022) IF: 4.9Products Cited: H9c2 (2-1) Cells Line -
Liraglutide inhibits receptor for advanced glycation end products (RAGE)/reduced form of nicotinamide-adenine dinucleotide phosphate (NAPDH) signaling to ameliorate non-alcoholic fatty liver disease (NAFLD) in vivo and vitro (2022-02-14)
Journal: Bioengineered (2022) IF: 4.9Products Cited: AML12 Cells Line -
RAB27B inhibits proliferation and promotes apoptosis of leukemic cells via 3-Hydroxy butyrate dehydrogenase 2 (BDH2) (2022-02-14)
Journal: Bioengineered (2022) IF: 4.9Products Cited: AML-193 Cells Line -
The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma (2022-02-15)
Journal: Bioengineered (2022) IF: 4.9Products Cited: Human Endometrial Epithelial cells, KLE Cells Line, RL95-2 Cells Line, Ishikawa Cells Line -
Low-density lipoprotein receptor-related protein 8 facilitates the proliferation and invasion of non-small cell lung cancer cells by regulating the Wnt/β-catenin signaling pathway (2022-03-04)
Journal: Bioengineered (2022) IF: 4.9Products Cited: HBE135-E6E7 Cells Line -
Oncogenic magnesium transporter 1 upregulates programmed death-1-ligand 1 expression and contributes to growth and radioresistance of glioma cells through the ERK/MAPK signaling pathway (2022-04-13)
Journal: Bioengineered (2022) IF: 4.9Products Cited: 1 M HEPES Solution -
Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression (2022-02-14)
Journal: Bioengineered (2022) IF: 4.9Products Cited: NCI-H1975 Cells Line, A549 [A-549] Cells Line -
Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma (2022-03-17)
Journal: Bioengineered (2022) IF: 4.9Products Cited: U-2 OS [U2OS] Cells Line, MG-63 Cells Line -
MicroRNA-137 inhibits the inflammatory response and extracellular matrix degradation in lipopolysaccharide-stimulated human nucleus pulposus cells by targeting activin a receptor type I (2022-03-02)
Journal: Bioengineered (2022) IF: 4.9Products Cited: Human Nucleus Pulposus cells
